期刊文献+

三碘甲酰原氨酸(T3)对内皮细胞凋亡的影响及护骨素干预研究 被引量:2

Effect of triiodothyronine( T3 ) on apoptosis of endothelial cells and interventional study with osteoprotegerin
原文传递
导出
摘要 目的探讨护骨素对不同浓度三碘甲酰原氨酸(L)下人脐静脉内皮细胞凋亡的影响及机制。方法将内皮细胞分组:对照组(0nmol/LT3)、低浓度组(0.1nmol/LT3)、生理浓度组(1nmol/LT,)和高浓度组(10nmoL/LL),护骨素干预48h后,Hoechst33258和流式细胞仪检测细胞凋亡情况;Western印迹分析各组细胞磷酸化NF.KB抑制蛋白激酶p(p-IKKl3)、NF.KB抑制蛋白激酶p(IKKl3)、磷酸化结节性硬化复合物2(p—TSC2)、结节性硬化复合物2(TSC2)、磷酸化核糖体蛋白S6激酶(p-S6K)、核糖体蛋白S6激酶(S6K)、磷酸化蛋白激酶B(p—AKT)、蛋白激酶B(AKT)、Bcl一2及Bax表达水平。结果(1)护骨素干预后的对照组、低浓度组、高浓度组细胞凋亡率低于未干预组(P〈0.05);生理浓度组护骨素干预前后细胞凋亡率无明显差异(P〉0.05)。(2)与生理浓度组相比,对照组、低浓度组和高浓度组p-IKKl3、p-S6K、Bax表达显著增高(P〈0.05),p-TSC2、p-AKT、Bel-2表达显著降低(P〈0.05);经护骨素干预后,对照组、低浓度组、高浓度组p-IKK[3、p-S6K、Bax低于未干预组(P〈0.05),而p-TSC2、p-AKT、Bel-2表达高于未干预组(P〈0.05):生理浓度组护骨素干预前后上述各蛋白表达无明显差异(P〉0.05)。结论低、高浓度甲状腺激素激活IKK[3/mTOR信号通路引起内皮细胞凋亡,而护骨素抑制其IKKl3/mTOR活性,对内皮细胞具有保护作用。 Objective To explore the effect and mechanism of osteoprotegerin on apoptosis in human umbilical vein endothelial cells(HUVECs) induced by triiodothyronine (T3 ) with different concentrations. Methods HUVECs were cultured in control group ( 0 mnol/L T3 ) , low-concentration group ( 0.1 nmol/L T3 ) , physiological- concentration group( I nmol/L T3 ) , high-concentration group( i0 nmol/L T3 ) with OPG for 48 h. The cell apoptosis was measured by cytometry and Hoechst 33258. The expressions of p-IRKS, IKKI3, p-TSC2, TSC2, p-S6K, S6K, p-AKT, AKT, Bcl-2, and Bax were analyzed by Western blot. Results ( 1 ) After OPG pretreatment and being cultured in control group, low-concentration group and high-concentration group, the HUVEC apoptosis was decreased significantly( P〈0.05 ) as compared with groups without OPG pretreatment. There was no difference in physiological concentration group before and after intervention of OPG. (2) The expression of p-IKK[3, p-S6K, and Bax in other groups were higher than those in physiological concentration group; however, the expressions of p-TSC2, p-AKT, and Bcl-2 were lower than those in physiological concentration group( P〈0.05 ). After OPG pretreatment in control group, low-concentration group, and high-concentration group, the expressions of p-IKK~, p-S6K, and Bax decreased significantly( P〈0.05 ) and the expression of p-TSC2, p-AKT, and Bcl-2 increased significantly ( P〈0.05 ) ; there were no differences in the expressions of p-IKKI3, p-S6K, p-TSC2, p-AKT, Bcl-2, and Bax in physiological concentration group before and after intervention of OPG. Conclusions Low and high concentrations of T3 increase apoptosis of HUVECs by way of activation of IKKI3/mTOR pathway. Osteoprotegerin is able to protect HUVECs from apoptosis induced by low and high concentration of T3 via the way of inhibiting the IKKβ/mTOR pathway.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第12期1056-1060,共5页 Chinese Journal of Endocrinology and Metabolism
基金 湖北省自然科学基金重点项目(2009CDB427) 湖北省科学技术研究与开发资金项目(2011CDA002) 武汉市学科带头人计划(201271130459)
关键词 血管内皮细胞 甲状腺激素 细胞凋亡 骨保护素 Vascular endothelial cells Triiodothyronine Apoptosis Osteoprotegefin
  • 相关文献

参考文献23

  • 1Bilir C, G?kosmanoglu F, Caliskan M, et al. Regression of the carotid intima media thickness by propylthiouracil therapy in Graves′ hyperthyroidism. Am J Med Sci, 2012,343:273-276.
  • 2Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol, 2010,52:151-156.
  • 3Xiang GD, Sun HL, Chen ZS, et al. Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patient. J Clin Endocrinol Metab, 2005,90:5765-5768.
  • 4Alibaz Oner F, Yurdakul S, Oner E, et al. Evaluation of the effect of L-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism. Endocrine, 2011,40:280-284.
  • 5王浩华,向光大.甲状腺激素对血管内皮细胞凋亡的影响[J].临床内科杂志,2012,29(9):637-639. 被引量:1
  • 6Reid P, Holen I. Pathophysiological roles of osteoprotegerin(OPG).
  • 7J Cell Biol, 2009,88:1-17.
  • 8Xiang GD, Sun HL, Hou J, et al. Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia. Clin Endocrinol (Oxf), 2008,69:799-803.
  • 9向林,向光大,王浩华,董靖.护骨素对高糖诱导损伤的血管内皮细胞的保护作用及机制研究[J].临床内科杂志,2012,29(3):200-203. 被引量:3
  • 10Mohan AL, Friedman MD, Ormond DR, et al. PI3K/mTOR signaling pathways in medulloblastoma. Anticancer Res, 2012,32:3141-3146.

二级参考文献8

  • 1向光大,孙慧伶,赵林双,侯洁,乐岭,徐琳.1型糖尿病患者胰岛素治疗前后血浆护骨素的变化[J].中华医学杂志,2007,87(18):1234-1237. 被引量:31
  • 2Hilir C, Gokosmanoglu F, Caliskan M, et a1. Regression of the carotid intima media thickness by propylthiouracil therapy in Graves' hyper?thyroidism. Am J Med Sci ,2012,343 :273-276.
  • 3Zonenberg A, Telejko B, Szelachowska M, et al. Markers of endothelial dysfunction in patients with iodine induced hyperthyroidism. Endokry?nol Pol ,2006,57 : 210-217.
  • 4Cunduz M, Gunduz E, KirceUi F, et al. Role of surrogate markers of ath?erosclerosis in clinical and subclinical thyroidism. Int J Endocrinol, 2012,2012:109797.
  • 5Cuang-da X. Hui-ling S. Zhi-song C. et al, Changes in plasma concen?trations of osteoprotegerin hefore and after levothyroxine replacement therapy in hypothyroid patient. J Clin Endocrinol Metab, 2005 , 90: 5765-5768.
  • 6Modzelewska A, Szelachowska M, Zonenberg A. et a1. Selected markers of endothelial dysfunction in patients with subclinical and overt hyper?thyroidism. Endokrynol PoI,57 :202-210.
  • 7J Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol , 2010,52 :l51-15fl.
  • 8Alibaz Oner F ? Yurdakul S, Oner E, et a1. Evaluation of the effect of L?thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism. Endoeri ne .2011 ,40 : 280 -284.

共引文献2

同被引文献43

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部